Salomon & Ludwin’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9K Sell
323
-321
-50% -$21.1K ﹤0.01% 1110
2026
Q1
$45.3K Buy
644
+295
+85% +$23.3K ﹤0.01% 533
2025
Q4
$29.7K Sell
349
-133
-28% -$10.4K ﹤0.01% 620
2025
Q3
$36.9K Buy
482
+369
+327% +$27.5K ﹤0.01% 476
2025
Q2
$8.6K Sell
113
-39
-26% -$2.71K ﹤0.01% 502
2025
Q1
$12.3K Hold
152
﹤0.01% 425
2024
Q4
$11.9K Sell
152
-36
-19% -$3.06K ﹤0.01% 428
2024
Q3
$17.6K Sell
188
-79
-30% -$6.63K ﹤0.01% 387
2024
Q2
$20.8K Sell
267
-114
-30% -$9.3K ﹤0.01% 364
2024
Q1
$34.6K Sell
381
-1
-0.3% -$83 ﹤0.01% 401
2023
Q4
$26K Hold
382
﹤0.01% 385
2023
Q3
$26K Buy
+382
New +$27.8K ﹤0.01% 385

Other funds holding GEHC

Salomon & Ludwin's GEHC Position: Q2 2026 in Review

Salomon & Ludwin reduced its GE HealthCare (GEHC) stake by 50% in Q2 2026, selling an estimated $21.1K and leaving 323 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Salomon & Ludwin first reported a position in GEHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $45.3K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Salomon & Ludwin held 323 shares of GE HealthCare worth $20.9K as of Q2 2026.
  • Salomon & Ludwin sold 321 GE HealthCare shares in Q2 2026, an estimated $21.1K.
  • GE HealthCare made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1110 holding.
  • Salomon & Ludwin first reported a position in GE HealthCare in Q3 2023 and has held it in 12 quarters since.
  • Salomon & Ludwin's GE HealthCare position peaked at $45.3K in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.